BBLG (Bone Biologics Corporation) Stock Financials & Earnings | Market Cap Arena

BBLG (Bone Biologics Corporation) Stock Financials & Earnings | Market Cap Arena

BBLGBone Biologics Corporation

Mkt Cap$2M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$3M

EPS (TTM)-$2.65

Free Cash Flow (TTM)-$3M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$3M
Q2 23	$0	$0	-$3M
Q3 23	$0	$0	-$2M
Q4 23	$0	$0	-$1M
Q1 24	$0	$0	-$904K
Q2 24	$0	$0	-$810K
Q3 24	$0	$0	-$951K
Q4 24	$0	$0	-$2M
Q1 25	$0	$0	-$1M
Q2 25	$0	$0	-$748K
Q3 25	$0	$0	-$715K
Q4 25	$0	$0	-$733K

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$1M	-$1M
Q2 23	-$4M	-$4M
Q3 23	-$3M	-$3M
Q4 23	-$2M	-$2M
Q1 24	-$1M	-$1M
Q2 24	-$896K	-$896K
Q3 24	-$572K	-$572K
Q4 24	-$1M	-$1M
Q1 25	-$926K	-$926K
Q2 25	-$459K	-$459K
Q3 25	-$591K	-$591K
Q4 25	-$715K	-$715K

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$5
Q2 25	$5
Q3 25	$0
Q4 25	$5

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+356.6%
Q2 23	—	+547.8%
Q3 23	—	+70.7%
Q4 23	—	-10.0%
Q1 24	—	-71.3%
Q2 24	—	-73.4%
Q3 24	—	-54.3%
Q4 24	—	+34.0%
Q1 25	—	+14.9%
Q2 25	—	-7.6%
Q3 25	—	-24.8%
Q4 25	—	-52.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$45K	—
Q2 23	$17K	—
Q3 23	$20K	—
Q4 23	$71K	—
Q1 24	$53K	—
Q2 24	$17K	—
Q3 24	$18K	—
Q4 24	$101K	—
Q1 25	$51K	—
Q2 25	$73K	—
Q3 25	$0	—
Q4 25	$46K	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$3M	$557K	—
Q2 23	$2M	$745K	—
Q3 23	$2M	$506K	—
Q4 23	$447K	$713K	—
Q1 24	$246K	—	$658K
Q2 24	$350K	—	$459K
Q3 24	$430K	—	$521K
Q4 24	$1M	—	$450K
Q1 25	$424K	—	$615K
Q2 25	$192K	$556K	—
Q3 25	$188K	$527K	—
Q4 25	$257K	$1M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$6M	$0	$6M
Q2 23	$7M	$0	$7M
Q3 23	$4M	$0	$4M
Q4 23	$3M	$0	$3M
Q1 24	$3M	$0	$3M
Q2 24	$2M	$0	$2M
Q3 24	$4M	$0	$4M
Q4 24	$3M	$0	$3M
Q1 25	$3M	$0	$3M
Q2 25	$7M	$0	$7M
Q3 25	$6M	$0	$6M
Q4 25	$5M	$0	$5M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	67K	+10.1%
Q2 23	339K	+404.8%
Q3 23	392K	+15.5%
Q4 23	459K	+17.1%
Q1 24	661K	+44.0%
Q2 24	1M	+76.7%
Q3 24	2M	+50.1%
Q4 24	3M	+68.5%
Q1 25	3M	+7.8%
Q2 25	558K	-82.5%
Q3 25	2M	+221.8%
Q4 25	1M	-34.6%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	—	—
FY 15	$0	3
FY 16	$0	3
FY 17	$0	3
FY 18	$0	3
FY 19	$0	3
FY 20	$0	3
FY 21	$0	2
FY 22	$0	2
FY 23	$0	2
FY 24	$0	2
FY 25	$0	2